View our Blog

Market Insights

Close

Subscribe to our newsletter

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.

RESEARCH AND NEWS

Empowering investors with access to the best research, experts and opportunities.

SUBSCRIBE

THIS WEEK'S NEWS

Prescient Therapeutics (ASX: PTX) Webcast Replay – 4 Feb 2026
In this session Prescient CEO James McDonnell discusses the outstanding PTX-100 Phase 1b results including the 64% tumor halt or reduction for a cancer considered a ‘death sentence’.
| 5 February 2026
Prescient Therapeutics (ASX: PTX) Webcast Replay – 4 Feb 2026
| 5 February 2026
Protected: Red Piranha – Live Investor Briefing
| 4 February 2026
Advanced Energy Minerals (ASX: AEM) Webcast Replay – 20th Jan
| 22 January 2026

More posts

Prescient Therapeutics (ASX: PTX) Webcast Replay – 4 Feb 2026
Protected: Red Piranha – Live Investor Briefing
Advanced Energy Minerals (ASX: AEM) Webcast Replay – 20th Jan
How this ASX listed company is positioned in the multi-billion critical minerals boom
Felix Gold (ASX: FXG) Webcast Replay
Pitt Street Research briefing on Prescient Therapeutics (ASX: PTX)
Prescient Therapeutics (ASX: PTX) Webcast Replay

WEBCASTS AND MEDIA

Prescient Therapeutics (ASX: PTX) Webcast Replay – 4 Feb 2026
| 5 February 2026
View All Webcasts
Join our next webcast

NEWS

See all news

RESEARCH

How this ASX listed company is positioned in the multi-billion critical minerals boom
| 21 January 2026
How individuals can unlock 13%+ yield private credit opportunities
| 18 August 2025
The Australian AI company aiming for a $1 billion+ exit
| 11 August 2025
Why the FDA backs ASX-biotech to revolutionise cancer treatment
| 4 July 2025
The Aussie mining veterans looking to build the largest exploration company on the planet
| 14 May 2025
Felix Gold: The Leading U.S. Antimony Solution at a Critical Moment
| 3 April 2025
See all research
Close
Search

Hit enter to search or ESC to close